What is Retatrutide?
Retatrutide is a groundbreaking triple receptor agonist that simultaneously activates GIP, GLP-1, and glucagon receptors. This tri-agonist approach represents the cutting edge of metabolic peptide research, combining the benefits of incretin activity with glucagon-mediated energy expenditure. Retatrutide has shown remarkable promise in research for substantial weight reduction and metabolic improvements, potentially offering advantages over dual-agonist peptides through its unique three-pathway activation mechanism.
Research Applications
- Triple receptor agonism mechanism studies
- Advanced energy expenditure research
- Maximum weight regulation investigation
- Metabolic flexibility and adaptation studies
- Novel therapeutic mechanism research
- Comparative multi-agonist analysis
- Body composition transformation research
Quick Product Specs
- Form: Lyophilized Powder
- CAS Number: Not publicly standardized
- Molecular Formula: Large synthetic peptide (sequence-specific; proprietary)
- Storage: -20°C (long-term) / 2–8°C after reconstitution
- Shelf Life: As indicated by manufacturer
- Type: Triple Receptor Agonist (GLP-1 / GIP / Glucagon Receptors)
Certificate of Analysis (COA)

https://verify.janoshik.com/tests/86681-Retatrutide_10mg_SKYPD9CJHB21




